4//SEC Filing
Bartushak Jaime 4
Accession 0001213900-24-109295
CIK 0001851484other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:06 PM ET
Size
7.2 KB
Accession
0001213900-24-109295
Insider Transaction Report
Form 4
Bartushak Jaime
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-12-12+400,000→ 400,000 totalExercise: $1.07Exp: 2034-12-12→ Common Stock (400,000 underlying)
Holdings
- 1,400,000
Stock Option (Right to Buy)
Exercise: $2.15Exp: 2033-07-05→ Common Stock (1,400,000 underlying)
Footnotes (2)
- [F1]These options were granted December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, provided that Optionee provides Continuous Service to the Company as of each such vesting date.
- [F2]These options vest over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services Continuous Service to the Company as of each such vesting date.
Documents
Issuer
CITIUS ONCOLOGY, INC.
CIK 0001851484
Entity typeother
Related Parties
1- filerCIK 0001725077
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 4:06 PM ET
- Size
- 7.2 KB